（一）活动时间、地点 本次年度报告业绩说明会于 2023 年 4 月 27 日（星期四）15:00-17:00 采 用网络方式举行， 投资者通过登陆全景网" 投资者关系互动平台" （https://ir.p5w.net）参与本次年度报告业绩说明会。 证券代码：871753 证券简称：天纺标 公告编号：2023-048 天纺标检测认证股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、投资者关系活动类别 □特定对象调研 二、投资者关系活动情况 （二）参与单位及人员 通过网络方式参与公司 2022 年年度报告业绩说明会的投资者。 （三）上市公司接待人员 公司董事长：葛传兵先生 公司总经理：吕刚先生 — 1 — ■业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 问题 1：您好！贵公司，最近三年营业收入持续下滑，请问对于未来营收， 公司有什么预判，是否有信心能够增长，谢谢！ 公司董事会秘书：张一姣女士 公司财务负责人：张娟女士 公司保荐代表 ...

证券代码：871753 证券简称：天纺标 公告编号：2023-046 天纺标检测认证股份有限公司 第二届董事会第三十三次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 2.会议召开地点：公司会议室 3.会议召开方式：现场及线上会议相结合 4.发出董事会会议通知的时间和方式：2023 年 4 月 21 日以书面送达会议通 知方式发出 5.会议主持人：葛传兵先生 6.会议列席人员：总经理、董事会秘书、监事会 7.召开情况合法、合规、合章程性说明： 本次董事会的召集、召开程序符合《公司法》等法律、法规、规章及《公 司章程》的规定，合法有效。 （二）会议出席情况 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 4 月 27 日 具体内容详见同日公司在北京证券交易所官网（http://www.bse.cn/）披 露的《天纺标检测认证股份有限公司 2023 年第一季度报告》（公告编号：2023- 045）。 2.议案表决结果：同意 9 票；反对 0 票；弃权 0 票。 3. ...

第二届监事会第十九次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 4 月 27 日 2.会议召开地点：公司会议室 证券代码：871753 证券简称：天纺标 公告编号：2023-047 天纺标检测认证股份有限公司 1.议案内容： 公司按相关要求编制了《2023 年第一季度报告》，真实、准确、完整地反 映了公司 2023 年第一季度的经营成果和财务状况，不存在任何虚假记载、误 3.会议召开方式：现场投票表决 4.发出监事会会议通知的时间和方式：2023 年 4 月 21 日以书面送达会议通知方 式发出 5.会议主持人：王秀玮女士 6.召开情况合法、合规、合章程性说明： 本次监事会的召集、召开程序符合《公司法》等法律、法规、规章及《公 司章程》和《监事会议事规则》的规定，合法有效 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 二、议案审议情况 （一）审议通过《2023 年第一季度报告》 导性 ...

Financial Performance - Operating revenue for Q1 2023 reached ¥27,254,687.17, representing a year-on-year increase of 7.56%[11] - Net profit attributable to shareholders for Q1 2023 was ¥3,711,694.51, a significant increase of 78.67% compared to the same period last year[11] - Basic earnings per share increased by 51.99% to ¥0.05 in Q1 2023[12] - Total operating revenue for Q1 2023 reached ¥27,254,687.17, an increase of 7.58% compared to ¥25,338,946.43 in Q1 2022[37] - Net profit for Q1 2023 was ¥4,665,557.76, compared to ¥2,901,645.74 in Q1 2022, representing an increase of about 61.5%[42] - Operating profit for Q1 2023 was ¥5,117,544.95, up from ¥3,354,544.27 in Q1 2022, indicating a growth of approximately 52.5%[42] - The company reported a total comprehensive income of ¥4,665,557.76 for Q1 2023, compared to ¥2,901,645.74 in Q1 2022, marking an increase of around 61.5%[43] - Basic earnings per share for Q1 2023 were ¥0.05, up from ¥0.03 in Q1 2022, reflecting a growth of 66.67%[39] Cash Flow - The net cash flow from operating activities increased by 37.75% to ¥6,338,345.10 in Q1 2023[12] - Cash inflow from operating activities in Q1 2023 was ¥37,148,520.80, slightly down from ¥37,300,578.49 in Q1 2022[44] - The net cash flow from operating activities for Q1 2023 was 7,473,505.98, an increase of 81.5% compared to 4,112,437.45 in Q1 2022[48] - Total cash inflow from operating activities reached 32,766,793.88, up from 29,385,044.48, reflecting a growth of 8.1% year-over-year[48] - Cash outflow from operating activities was 25,293,287.90, slightly increased from 25,272,607.03, indicating a marginal rise of 0.08%[48] - The ending cash and cash equivalents balance for Q1 2023 was 203,361,073.08, compared to 61,206,484.81 in Q1 2022, marking a substantial increase of 232.5%[48] - The total cash and cash equivalents increased by 4,299,191.27 in Q1 2023, compared to an increase of 3,773,283.39 in Q1 2022, reflecting a growth of 13.9%[48] - The company reported a cash inflow from sales of goods and services of 30,603,230.39, up from 28,520,599.50, which is a growth of 7.3% year-over-year[48] - The cash flow from other operating activities increased to 2,163,563.49 from 864,444.98, representing a significant increase of 150.1%[48] Assets and Liabilities - Total assets as of March 31, 2023, amounted to ¥446,943,781.81, a decrease of 0.66% compared to the end of 2022[11] - The company's asset-liability ratio decreased to 3.33% for the parent company and 5.48% for the consolidated entity, down from 4.32% and 6.73% respectively[11] - Total liabilities decreased to ¥24,493,916.96 in Q1 2023 from ¥30,299,701.05 at the end of 2022, a reduction of 19.2%[31] - Current liabilities decreased to ¥14,914,237.43 in Q1 2023 from ¥19,922,321.68 at the end of 2022, a decline of 25.3%[31] - Non-current liabilities decreased to ¥9,579,679.53 in Q1 2023 from ¥10,377,379.37 at the end of 2022, a decrease of 7.7%[31] - Shareholders' equity increased to ¥422,449,864.85 in Q1 2023 from ¥419,592,517.60 at the end of 2022, an increase of 0.85%[31] Research and Development - Research and development expenses rose by 8.92% due to increased salaries for R&D personnel and equipment depreciation[14] - Research and development expenses for Q1 2023 totaled ¥1,850,120.27, compared to ¥1,760,381.08 in Q1 2022, indicating an increase of about 5.1%[42] Other Income and Expenses - Other income surged by 526.61% to ¥3,000,000, primarily due to new listing subsidies[14] - The company recorded other income of ¥3,179,931.52 in Q1 2023, significantly higher than ¥202,264.08 in Q1 2022, showing a substantial increase[42] - The total operating costs for Q1 2023 were ¥11,351,060.11, compared to ¥10,464,514.78 in Q1 2022, reflecting an increase of approximately 8.5%[42] - The company reported a decrease in tax expenses to ¥455,671.56 in Q1 2023 from ¥452,659.98 in Q1 2022, indicating a slight reduction[42] Shareholder Information - The total number of ordinary shareholders as of the report date was 8,840[20] - Total equity held by the top ten shareholders is 67,924,003 shares, representing 83.44% of the total shares[22] - Tianjin Tianfang Investment Holding Co., Ltd. holds 60.07% of the shares, making it the largest shareholder[22] Compliance and Legal Matters - The company has no outstanding litigation or arbitration matters reported during the period[25] - There were no significant external guarantees or loans provided by the company[25] - The company has complied with all disclosed commitments as per the prospectus[25] - No major related party transactions were reported during the period[25]

证券代码：871753 证券简称：天纺标 公告编号：2023-044 天纺标检测认证股份有限公司 2022 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 天纺标检测认证股份有限公司（以下简称"公司"）于 2023 年 4 月 20 日在 北京证券交易所官方信息披露平台（http://www.bse.cn/)发布了《天纺标检测 认证股份有限公司 2022 年年度报告》（公告编号：2023-026），为方便广大投资 者更深入了解公司 2022 年年度经营业绩的具体情况，加强与投资者的互动交流， 公司拟召开 2022 年年度报告业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2022 年 4 月 27 日 15:00-17:00。 （二）会议召开地点 本次业绩说明会将采用网络远程的方式举行，投资者可登录全景网"投资者 关系互动平台"（https://ir.p5w.net）参与。 三、 参加人员 公司董事长：葛传兵先生 公司总经理：吕刚先生 公司 ...

证券代码：871753 证券简称：天纺标 公告编号：2023-044 天纺标检测认证股份有限公司 2022 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 三、 参加人员 公司董事长：葛传兵先生 公司总经理：吕刚先生 公司董事会秘书：张一姣女士 公司财务负责人：张娟女士 公司保荐代表人：丁和伟先生 天纺标检测认证股份有限公司（以下简称"公司"）于 2023 年 4 月 20 日在 北京证券交易所官方信息披露平台（http://www.bse.cn/)发布了《天纺标检测 认证股份有限公司 2022 年年度报告》（公告编号：2023-026），为方便广大投资 者更深入了解公司 2022 年年度经营业绩的具体情况，加强与投资者的互动交流， 公司拟召开 2022 年年度报告业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2022 年 4 月 27 日 15:00-17:00。 （二）会议召开地点 本次业绩说明会将采用网络远程的方式举行，投资者可登录 ...

证券代码：871753 证券简称：天纺标 公告编号：2023-021 天纺标检测认证股份有限公司 第二届监事会第十八次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 4 月 20 日 2.会议召开地点：公司会议室 3.会议召开方式：现场投票表决 4.发出监事会会议通知的时间和方式：2023 年 4 月 10 日以书面送达会议通知方 式发出 5.会议主持人：王秀玮女士 6.召开情况合法、合规、合章程性说明： 本次监事会的召集、召开程序符合《公司法》等法律、法规、规章及《公司 章程》和《监事会议事规则》的规定，合法有效。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 3.回避表决情况 二、议案审议情况 （一）审议通过《2022 年度监事会工作报告》 1.议案内容： 依据公司监事会 2022 年度工作情况及公司年度经营状况，公司监事会组织 编写了《2022 年度监事会工作报告》。 2.议案表决 ...

证券代码：871753 证券简称：天纺标 公告编号：2023-041 天纺标检测认证股份有限公司 独立董事候选人声明（岳殿民） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 本人岳殿民，已充分了解并同意由提名人天纺标检测认证股份有限公司董事 会提名为天纺标检测认证股份有限公司第三届董事会独立董事候选人。本人公开 声明，本人具备独立董事任职资格，保证不存在任何影响本人担任天纺标检测认 证股份有限公司独立董事独立性的关系，具体声明如下： 一、本人已同时符合以下条件： 二、本人任职资格符合下列法律法规、部门规章和规范性文件及北京证券交 易所业务规则的要求： （一）《公司法》关于董事任职资格的规定； （二）《公务员法》的相关规定； （三）中央纪委、中央组织部《关于规范中管干部辞去公职或者退（离）休 后担任上市公司、基金管理公司独立董事、独立监事的通知》的相关规定； （四）中央组织部《关于进一步规范党政领导干部在企业兼职（任职）问题 的意见》的相关规定； （五）中央纪委、教育部、监察部《关于加强高等学校反腐倡廉 ...

证券代码：871753 证券简称：天纺标 公告编号：2023-020 天纺标检测认证股份有限公司 独立董事关于第二届董事会第三十二次会议相关事项的独立意见 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 天纺标检测认证股份有限公司（以下简称"公司"）第二届董事会第三十二 次会议于 2023 年 4 月 20 日召开，作为公司的独立董事，根据《公司法》《证券 法》《北京证券交易所上市公司持续监管指引第 1 号——独立董事》《天纺标检 测认证股份有限公司章程》《天纺标检测认证股份有限公司独立董事工作制度》 的相关规定，本着谨慎的原则，基于独立判断的立场，我们对第二届董事会第三 十二次会议审议的相关事项发表如下独立意见： 一、关于《2022 年年度报告及 2022 年年度报告摘要》的独立意见 我们一致同意《关于提请股东大会授权董事会办理权益分派相关事宜的议 案》，并同意提交股东大会审议。 四、关于《2022 年度募集资金存放及实际使用情况的专项报告》的独立意 见 经审阅相关会议材料，我们一致认为，公司 202 ...

Company Overview - TianFangBiao successfully listed on the Beijing Stock Exchange on October 31, 2022, after receiving approval from the China Securities Regulatory Commission on September 27, 2022[5]. - The company established a subsidiary, TianFangBiao Biomedical (Tianjin) Co., Ltd., in November 2022 to further expand its life sciences segment[6]. - The company is recognized as a "High-tech Enterprise" and a "Tianjin Gazelle Enterprise" by the Tianjin Science and Technology Bureau[47]. - The company aims to become a leading domestic and internationally recognized comprehensive authority testing institution, focusing on intelligent testing laboratories and enhancing technological innovation capabilities[111]. Financial Performance - TianFangBiao's financial report for the year ending December 31, 2022, was audited and received a standard unqualified opinion from Zhongshun Hua Accounting Firm[14]. - The company's operating revenue for 2022 was CNY 142,633,060.05, a decrease of 8.54% compared to CNY 155,958,251.40 in 2021[34]. - The net profit attributable to shareholders for 2022 was CNY 33,030,410.94, down 10.61% from CNY 36,952,376.88 in 2021[34]. - The gross profit margin for 2022 was 53.98%, a decline from 58.45% in 2021[34]. - Total assets increased by 45.79% to CNY 449,892,218.65 at the end of 2022, compared to CNY 308,594,182.03 at the end of 2021[35]. - The company's net assets attributable to shareholders rose by 56.45% to CNY 407,596,217.18 in 2022, up from CNY 260,529,013.71 in 2021[35]. - The company reported a basic earnings per share of CNY 0.47 for 2022, a decrease of 12.96% from CNY 0.54 in 2021[34]. - The net cash flow from operating activities for 2022 was CNY 44,682,941.43, down 5.86% from CNY 47,462,344.61 in 2021[36]. Market and Competition - The company continues to face significant market competition from foreign third-party testing institutions entering the Chinese market[52]. - The inspection and testing service market in China reached a scale of CNY 358.592 billion in 2020, with a compound annual growth rate of 14.40% since 2013[106]. - The company is focused on expanding its testing capabilities across various sectors, including military-civilian integration and e-commerce platforms[112]. Risks and Challenges - The company faces risks related to internal control as it expands, necessitating adjustments in resource integration and market development[16]. - There is a notable risk of talent shortage and technology leakage in the testing industry, which could impact sustainable business development[16]. - Revenue recognition has been identified as a key audit matter due to the inherent risk of inappropriate revenue recognition to meet specific targets[99]. - The company acknowledges risks related to internal control as it expands, emphasizing the need for improved management and coordination among departments[117]. Research and Development - The company continues to leverage its expertise in quality inspection services, focusing on textiles, apparel, and related products, to enhance its market presence and authority[45]. - Research and development expenses rose by 9.90% to CNY 10.57 million, reflecting increased personnel costs and collaborative research expenses[59]. - The company has established a quality control plan that includes participation in capability verification and inter-laboratory comparisons to ensure high-quality testing operations[182]. - The company has a stable core technical team during the reporting period, ensuring continuity in expertise[178]. Corporate Governance - The company has established a modern corporate governance structure to improve management efficiency[132]. - The board consists of 9 members, including 3 independent directors, ensuring compliance with governance standards and protection of minority shareholders' rights[198]. - The company is committed to transparency and accountability in its financial reporting and decision-making processes[198]. - The company has established a comprehensive governance mechanism, ensuring protection and equal rights for all shareholders, particularly minority shareholders[187]. Shareholder and Stock Information - The largest shareholder, Tianjin Tianfang Investment Holding Co., Ltd., holds 48,902,903 shares, representing 60.07% of total shares[145]. - The company completed a public offering of 13,000,000 ordinary shares, increasing total share capital from 68,404,368 shares to 81,404,368 shares[142]. - The company has committed to stabilizing its stock price for three years post-IPO, initiating measures if the stock price falls below the audited net asset value per share for 20 consecutive trading days[130]. Future Plans and Strategies - The company plans to deepen its core business in textile testing and expand into food and environmental testing through mergers and acquisitions[114]. - The company will implement five key actions to enhance market development and customer maintenance, focusing on proactive service and customer relationship management[114]. - The company intends to enhance its capabilities in strategic emerging industries such as intelligent manufacturing and ecological protection, while developing the life sciences testing sector[114].